Menopause Completed Phase 3 Trials for Esmirtazapine (DB06678)

Also known as: Menopausal

IndicationStatusPhase
DBCOND0025857 (Menopause)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00560833Dose-Finding Safety and Efficacy Trial of Org50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (46101/P06459/MK-8265-012)Treatment
NCT00535288Dose-Finding Safety and Efficacy Trial of Org 50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (177001/P06472/MK-8265-013)Treatment